Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study Group.
Dmoszynska A, Walter-Croneck A, Hus I, Grzasko N, Manko J, Jedrzejczak WW, Charlinski G, Usnarska-Zubkiewicz L, Skotnicki A, Wolska-Smolen T, Piszcz J, Kloczko J. Dmoszynska A, et al. Among authors: wolska smolen t. Leuk Res. 2010 Oct;34(10):1330-5. doi: 10.1016/j.leukres.2010.05.003. Epub 2010 Jun 2. Leuk Res. 2010. PMID: 20627385
The use of the Congo red-related dye DBACR to recognize the heavy chain-derived abnormality of myeloma immunoglobulins.
Spólnik P, Konieczny L, Piekarska B, Rybarska J, Stopa B, Zemanek G, Drozd A, Król M, Roterman I, Wolska-Smoleń T, Skotnicki AB. Spólnik P, et al. Among authors: wolska smolen t. Arch Immunol Ther Exp (Warsz). 2006 May-Jun;54(3):217-21. doi: 10.1007/s00005-006-0024-0. Epub 2006 May 31. Arch Immunol Ther Exp (Warsz). 2006. PMID: 16736107 Free article.
15 results